Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry

Journal of Proteome Research

Volumn 14, Issue 5, 2015, Pages 2322-2330

  Liu, Xinyu ^a   Zheng, Peng ^b,c   Zhao, Xinjie ^a   Zhang, Yuqing ^b,c   Hu, Chunxiu ^a   Li, Jia ^a   Zhao, Jieyu ^a   Zhou, Jingjing ^b,c   Xie, Peng ^b,c   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

diagnosis biomarker; LC MS; major depressive disorder; metabolomics

Indexed keywords

ACYL CARNITINE; BIOLOGICAL MARKER; CARNITINE; DEOXYCHOLIC ACID; ETHER LIPID; ETHER PHOSPHOLIPID; FATTY ACID; GLYCEROPHOSPHOLIPID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LITHOCHOLIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLETHANOLAMINE; METHIONINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A2; TRIACYLGLYCEROL; TRYPTOPHAN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID;

ADULT; AGE; AMINO ACID METABOLISM; ARTICLE; BILE ACID METABOLISM; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLOMICS; OXIDATIVE STRESS; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TRYPTOPHAN METABOLISM; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; DEPRESSIVE DISORDER, MAJOR; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; BIOMARKERS; CARNITINE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LIPID METABOLISM; LOGISTIC MODELS; LYSOPHOSPHATIDYLCHOLINES; LYSOPHOSPHOLIPIDS; MALE; METABOLOME; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINES; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRYPTOPHAN;

EID: 84929660342     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00144     Document Type: Article

References (59)

1. Martins-de-Souza, D. Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder Dialogues Clin. Neurosci. 2014, 16 (1) 63-73
2. Pariante, C. M.; Lightman, S. L. The HPA axis in major depression: classical theories and new developments Trends Neurosci. 2008, 31 (9) 464-468
3. Sheline, Y. I.; Wang, P. W.; Gado, M. H.; Csernansky, J. G.; Vannier, M. W. Hippocampal atrophy in recurrent major depression Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (9) 3908-3913
4. Campbell, S.; MacQueen, G. The role of the hippocampus in the pathophysiology of major depression J. Psychiatry Neurosci. 2004, 29 (6) 417-426
5. Ongur, D.; Drevets, W. C.; Price, J. L. Glial reduction in the subgenual prefrontal cortex in mood disorders Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (22) 13290-13295
6. Mitchell, A. J.; Vaze, A.; Rao, S. Clinical diagnosis of depression in primary care: a meta-analysis Lancet 2009, 374 (9690) 609-619
7. Smith, K. M.; Renshaw, P. F.; Bilello, J. The diagnosis of depression: current and emerging methods Compr. Psychiatry 2013, 54 (1) 1-6
8. Le-Niculescu, H.; Kurian, S. M.; Yehyawi, N.; Dike, C.; Patel, S. D.; Edenberg, H. J.; Tsuang, M. T.; Salomon, D. R.; Nurnberger, J. I., Jr.; Niculescu, A. B. Identifying blood biomarkers for mood disorders using convergent functional genomics Mol. Psychiatry 2009, 14 (2) 156-174
9. Spijker, S.; Van Zanten, J. S.; De Jong, S.; Penninx, B. W.; van Dyck, R.; Zitman, F. G.; Smit, J. H.; Ylstra, B.; Smit, A. B.; Hoogendijk, W. J. Stimulated gene expression profiles as a blood marker of major depressive disorder Biol. Psychiatry 2010, 68 (2) 179-186
10. Yang, Y.; Yang, D.; Tang, G.; Zhou, C.; Cheng, K.; Zhou, J.; Wu, B.; Peng, Y.; Liu, C.; Zhan, Y.; Chen, J.; Chen, G.; Xie, P. Proteomics reveals energy and glutathione metabolic dysregulation in the prefrontal cortex of a rat model of depression Neuroscience 2013, 247, 191-200
11. Zheng, P.; Wang, Y.; Chen, L.; Yang, D.; Meng, H.; Zhou, D.; Zhong, J.; Lei, Y.; Melgiri, N. D.; Xie, P. Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder Mol. Cell. Proteomics 2013, 12 (1) 207-214
12. Huang, Q.; Tan, Y.; Yin, P.; Ye, G.; Gao, P.; Lu, X.; Wang, H.; Xu, G. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics Cancer Res. 2013, 73 (16) 4992-5002
13. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457 (7231) 910-914
14. Jain, M.; Nilsson, R.; Sharma, S.; Madhusudhan, N.; Kitami, T.; Souza, A. L.; Kafri, R.; Kirschner, M. W.; Clish, C. B.; Mootha, V. K. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation Science 2012, 336 (6084) 1040-1044
15. Shi, B.; Tian, J.; Xiang, H.; Guo, X.; Zhang, L.; Du, G.; Qin, X. A (1)H-NMR plasma metabonomic study of acute and chronic stress models of depression in rats Behav. Brain Res. 2013, 241, 86-91
16. Liu, X. J.; Li, Z. Y.; Li, Z. F.; Gao, X. X.; Zhou, Y. Z.; Sun, H. F.; Zhang, L. Z.; Guo, X. Q.; Du, G. H.; Qin, X. M. Urinary metabonomic study using a CUMS rat model of depression Magn. Reson. Chem. 2012, 50 (3) 187-192
17. 1H NMR and UPLC-MS-based plasma metabonomic study to investigate the biochemical changes in chronic unpredictable mild stress model of depression Metabolomics 2010, 7 (3) 413-423
18. Jia, H. M.; Feng, Y. F.; Liu, Y. T.; Chang, X.; Chen, L.; Zhang, H. W.; Ding, G.; Zou, Z. M. Integration of (1)H NMR and UPLC-Q-TOF/MS for a comprehensive urinary metabonomics study on a rat model of depression induced by chronic unpredictable mild stress PLoS One 2013, 8 (5) e63624
19. Ni, Y.; Su, M.; Lin, J.; Wang, X.; Qiu, Y.; Zhao, A.; Chen, T.; Jia, W. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress FEBS Lett. 2008, 582 (17) 2627-2636
20. Wang, X.; Zhao, T.; Qiu, Y.; Su, M.; Jiang, T.; Zhou, M.; Zhao, A.; Jia, W. Metabonomics Approach to Understanding Acute and Chronic Stress in Rat Models J. Proteome Res. 2009, 8 (5) 2511-2518
21. Shao, W. H.; Fan, S. H.; Lei, Y.; Yao, G. E.; Chen, J. J.; Zhou, J.; Xu, H. B.; Liu, H. P.; Wu, B.; Zheng, P.; Fang, L.; Xie, P. Metabolomic identification of molecular changes associated with stress resilience in the chronic mild stress rat model of depression Metabolomics 2013, 9, 433-443
22. Zheng, P.; Chen, J. J.; Huang, T.; Wang, M. J.; Wang, Y.; Dong, M. X.; Huang, Y. J.; Zhou, L. K.; Xie, P. A novel urinary metabolite signature for diagnosing major depressive disorder J. Proteome Res. 2013, 12 (12) 5904-5911
23. Theodoridis, G. A.; Gika, H. G.; Want, E. J.; Wilson, I. D. Liquid chromatography-mass spectrometry based global metabolite profiling: a review Anal. Chim. Acta 2012, 711, 7-16
24. Forcisi, S.; Moritz, F.; Kanawati, B.; Tziotis, D.; Lehmann, R.; Schmitt-Kopplin, P. Liquid chromatography-mass spectrometry in metabolomics research: mass analyzers in ultra high pressure liquid chromatography coupling J. Chromatogr., A 2013, 1292, 51-65
25. Zhao, Y. Y.; Lin, R. C. UPLC-MS(E) application in disease biomarker discovery: The discoveries in proteomics to metabolomics Chem. Biol. Interact. 2014, 215, 7-16
26. Uher, R.; Payne, J. L.; Pavlova, B.; Perlis, R. H. Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV Depression Anxiety 2014, 31 (6) 459-471
27. Kriston, L.; von Wolff, A. Not as golden as standards should be: interpretation of the Hamilton Rating Scale for Depression J. Affective Disord. 2011, 128 (1-2) 175-177
28. Sevincok, L.; Buyukozturk, A.; Dereboy, F. Serum Lipid Concentrations in Patients With Comorbid Generalized Anxiety Disorder and Major Depressive Disorder Can. J. Psychiatry. 2001, 46 (1) 68-71
29. Hamilton, M. A rating scale for depression J. Neurol., Neurosurg. Psychiatry 1960, 23 (1) 56-62
30. Williams, J. B. Standardizing the Hamilton Depression Rating Scale: past, present, and future Eur. Arch. Psychiatry Clin. Neurosci. 2001, 251 (Suppl 2) II6-II12
31. Ren, J.; Lakoski, S.; Haller, R. G.; Sherry, A. D.; Malloy, C. R. Dynamic monitoring of carnitine and acetylcarnitine in the trimethylamine signal after exercise in human skeletal muscle by 7T 1H-MRS Magn. Reson. Med. 2013, 69 (1) 7-17
32. Boss, A.; Kreis, R.; Jenni, S.; Ith, M.; Nuoffer, J. M.; Christ, E.; Boesch, C.; Stettler, C. Noninvasive assessment of exercise-related intramyocellular acetylcarnitine in euglycemia and hyperglycemia in patients with type 1 diabetes using (1)H magnetic resonance spectroscopy: a randomized single-blind crossover study Diabetes Care 2011, 34 (1) 220-222
33. Beal, M. F. Bioenergetic approaches for neuroprotection in Parkinson's disease Ann. Neurol. 2003, 53 (Suppl 3) S39-S47 discussion S47-S48
34. Malaguarnera, M.; Bella, R.; Vacante, M.; Giordano, M.; Malaguarnera, G.; Gargante, M. P.; Motta, M.; Mistretta, A.; Rampello, L.; Pennisi, G. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy Scand. J. Gastroenterol. 2011, 46 (6) 750-759
35. Nasca, C.; Xenos, D.; Barone, Y.; Caruso, A.; Scaccianoce, S.; Matrisciano, F.; Battaglia, G.; Mathe, A. A.; Pittaluga, A.; Lionetto, L.; Simmaco, M.; Nicoletti, F. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (12) 4804-4809
36. Pettegrew, J. W.; Levine, J.; McClure, R. J. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties relevance for its mode of action in Alzheimer's disease and geriatric depression Mol. Psychiatry 2000, 5 (6) 616-632
37. Pettegrew, J. W.; McClure, R. J. Acetyl-l-carnitine as a possible therapy for Alzheimer's disease Expert Rev. Neurother. 2002, 2 (5) 647-654
38. Lehmann, R.; Zhao, X.; Weigert, C.; Simon, P.; Fehrenbach, E.; Fritsche, J.; Machann, J.; Schick, F.; Wang, J.; Hoene, M.; Schleicher, E. D.; Häring, H. U.; Xu, G.; Niess, A. M. Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation PLoS One 2010, 5 (7) e11519
39. Zheng, P.; Gao, H. C.; Li, Q.; Shao, W. H.; Zhang, M. L.; Cheng, K.; Yang de, Y.; Fan, S. H.; Chen, L.; Fang, L.; Xie, P. Plasma metabonomics as a novel diagnostic approach for major depressive disorder J. Proteome Res. 2012, 11 (3) 1741-1748
40. Zhang, F.; Jia, Z.; Gao, P.; Kong, H.; Li, X.; Lu, X.; Wu, Y.; Xu, G. Metabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry Mol. Biosyst 2010, 6 (5) 852-861
41. Papadimitriou, G. N.; Dikeos, D. G.; Souery, D.; Del-Favero, J.; Massat, I.; Avramopoulos, D.; Blairy, S.; Cichon, S.; Ivezic, S.; Kaneva, R.; Karadima, G.; Lilli, R.; Milanova, V.; Nothen, M.; Oruc, L.; Rietschel, M.; Serretti, A.; Van Broeckhoven, C.; Stefanis, C. N.; Mendlewicz, J. Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case-control study Psychiatr. Genet. 2003, 13 (4) 211-220
42. Zou, Y.; Kim, D. H.; Jung, K. J.; Heo, H. S.; Kim, C. H.; Baik, H. S.; Yu, B. P.; Yokozawa, T.; Chung, H. Y. Lysophosphatidylcholine enhances oxidative stress via the 5-lipoxygenase pathway in rat aorta during aging Rejuvenation Res. 2009, 12 (1) 15-24
43. Matsumoto, T.; Kobayashi, T.; Kamata, K. Role of Lysophosphatidylcholine (LPC) in Atherosclerosis Curr. Med. Chem. 2007, 14 (30) 3209-3220
44. Battelli, M. G.; Polito, L.; Bolognesi, A. Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress Atherosclerosis 2014, 237 (2) 562-567
45. Kim, E. A.; Kim, J. A.; Park, M. H.; Jung, S. C.; Suh, S. H.; Pang, M. G.; Kim, Y. J. Lysophosphatidylcholine induces endothelial cell injury by nitric oxide production through oxidative stress J. Matern. Fetal Neonatal. Med. 2009, 22 (4) 325-331
46. Michel, T. M.; Pülschen, D.; Thome, J. The Role of Oxidative Stress in Depressive Disorders Curr. Pharm. Des. 2012, 18 (36) 5890-5899
47. Kokacya, M. H.; Bahceci, B.; Bahceci, I.; Dilek, A. R.; Dokuyucu, R. Prolidase activity and oxidative stress in patients with major depressive disorder Psychiatr. Danubina 2014, 26 (4) 314-318
48. Yanik, M.; Erel, O.; Kati, M. The relationship between potency of oxidative stress and severity of depression Acta Neuropsychiatrica 2004, 16 (4) 200-203
49. Horrobin, D. F. Phospholipid Metabolism and Depression: the Possible Roles of Phospholipase A2 and Coenzyme A-Independent Transacylase Hum. Psychopharmacol. 2001, 16 (1) 45-52
50. Farooqui, A. A.; Horrocks, L. A.; Farooqui, T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders Chem. Phys. Lipids 2000, 106 (1) 1-29
51. Demirkan, A.; Isaacs, A.; Ugocsai, P.; Liebisch, G.; Struchalin, M.; Rudan, I.; Wilson, J. F.; Pramstaller, P. P.; Gyllensten, U.; Campbell, H.; Schmitz, G.; Oostra, B. A.; van Duijn, C. M. Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study J. Psychiatr Res. 2013, 47 (3) 357-362
52. Engelmann, B. Plasmalogens targets for oxidants and major lipophilic antioxidants Biochem. Soc. Trans. 2004, 32 (Pt 1) 147-150
53. Brosche, T.; Bertsch, T.; Sieber, C. C.; Hoffmann, U. Reduced plasmalogen concentration as a surrogate marker of oxidative stress in elderly septic patients Arch. Gerontol. Geriatr. 2013, 57 (1) 66-69
54. Brosche, T.; Brueckmann, M.; Haase, K. K.; Sieber, C.; Bertsch, T. Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias Clin. Chem. Lab. Med. 2007, 45 (5) 689-691
55. Esteban, S.; Garau, C.; Aparicio, S.; Moranta, D.; Barceló, P.; Fiol, M. A.; Rial, R. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain J. Pineal Res. 2010, 48 (2) 170-177
56. Storga, D.; Vrecko, K.; Birkmayer, J. G.; Reibnegger, G. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients Neurosci. Lett. 1996, 203 (1) 29-32
57. Morrissette, D. A.; Stahl, S. M. Modulating the serotonin system in the treatment of major depressive disorder CNS Spectrums 2014, 19 (Suppl 1) 54-68
58. Belmaker, R. H.; Agam, G. Mechanisms of disease: Major depressive disorder. New Engl. J. Med. 2008, 358, 55-68
59. Khaliq, S.; Haider, S.; Ahmed, S. P.; Perveen, T.; Haleem, D. J. Relationship of brain tryptophan and serotonin in improving cognitive performance in rats Pak. J. Pharm. Sci. 2006, 19 (1) 11-15